173 related articles for article (PubMed ID: 7555671)
21. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
[TBL] [Abstract][Full Text] [Related]
22. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
23. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
[TBL] [Abstract][Full Text] [Related]
24. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
[TBL] [Abstract][Full Text] [Related]
25. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
26. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
Campos Nizama J
Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
[TBL] [Abstract][Full Text] [Related]
27. Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers.
Reutter J; Bart PA; Francioli P; Safary A; Frei PC
J Viral Hepat; 1998 May; 5(3):205-11. PubMed ID: 9658375
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous vaccination against hepatitis A and B: results of a controlled study.
Ambrosch F; André FE; Delem A; D'Hondt E; Jonas S; Kunz C; Safary A; Wiedermann G
Vaccine; 1992; 10 Suppl 1():S142-5. PubMed ID: 1335647
[TBL] [Abstract][Full Text] [Related]
29. Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.
De Schryver A; Verstrepen K; Vandersmissen L; Vandermeeren N; Vernaillen I; Vranckx R; Van Damme P; van Sprundel M
J Viral Hepat; 2011 Apr; 18(4):e5-10. PubMed ID: 20735800
[TBL] [Abstract][Full Text] [Related]
30. Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine.
Hoke CH; Egan JE; Sjogren MH; Sanchez J; DeFraites RF; MacArthy PO; Binn LN; Rice R; Burke A; Hill J
J Infect Dis; 1995 Mar; 171 Suppl 1():S53-60. PubMed ID: 7876650
[TBL] [Abstract][Full Text] [Related]
31. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
Van Herck K; Van Damme P; Collard F; Thoelen S
Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
[TBL] [Abstract][Full Text] [Related]
33. [Active immunization against hepatitis A. Comparison of various immunization schedules].
Müller R; Bock HL; Clemens R; Jilg W
Dtsch Med Wochenschr; 1993 Aug; 118(31):1101-4. PubMed ID: 8393760
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
[TBL] [Abstract][Full Text] [Related]
35. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination.
Kuramoto I; Fujiyama S; Matsushita K; Sato T
J Gastroenterol Hepatol; 1994; 9(3):228-31. PubMed ID: 8054520
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and reactogenicity of a combined hepatitis A-hepatitis B vaccine in adolescents.
Thompson SC; Norris M
Int J Infect Dis; 1998; 2(4):193-6. PubMed ID: 9763500
[TBL] [Abstract][Full Text] [Related]
37. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.
Urganci N; Kalyoncu D
J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120
[TBL] [Abstract][Full Text] [Related]
38. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?
Kallinowski B; Knöll A; Lindner E; Sänger R; Stremmel W; Vollmar J; Zieger B; Jilg W
Vaccine; 2000 Aug; 19(1):16-22. PubMed ID: 10924782
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.
Chen XQ; Bülbül M; de Gast GC; van Loon AM; Nalin DR; van Hattum J
J Hepatol; 1997 Feb; 26(2):260-4. PubMed ID: 9059944
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children.
Guptan RC; Thakur V; Safary A; Sarin SK
Vaccine; 2002 May; 20(16):2102-6. PubMed ID: 11972979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
